Compare TG Therapeutics Inc (TGTX) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Tilray Brands Inc — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Tilray Brands Inc trades at $4.24 (market cap $524.07M). The key difference: TG Therapeutics Inc is far larger — about 15.8× Tilray Brands Inc's market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| TGTX | TLRY | |
|---|---|---|
Market Cap | $8.26B | $524.07M |
Sector | Health | Health |
52-Week High | $59.06 | $21.00 |
52-Week Low | $26.39 | $4.23 |
Enterprise Value | $8.50B | $621.22M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
